EUVIMEDEUVIMED entdecken
Crossref

Kynurenine 3-monooxygenase limits de novo NAD + synthesis through dietary tryptophan in renal proximal tubule epithelial cell models

Yougang Zhai iD, Jose A Chavez, Katharine E D'Aquino, Rong Meng, Andrea R Nawrocki, Alessandro Pocai, Lifeng Wang, Li-Jun Ma

American Journal of Physiology-Cell Physiology · 2024

DOI: 10.1152/ajpcell.00445.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Yougang Zhai und 7 weiteren Autor:innen. Beteiligte Einrichtung: CVMR-PH Discovery, Johnson & Johnson Innovative Medicine Research & Development, Spring House, Pennsylvania, United States. Hauptthemen laut MEDLINE: Epithelial Cells, Kidney Tubules, Proximal, Kynurenine 3-Monooxygenase, NAD. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Auris | J&J | Janssen Research and Development (JRD), Johnson & Johnson Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide adenine dinucleotide (NAD + ) is essential in regulating mitochondrial function. Reduced NAD + synthesis through the de novo pathway is associated with acute kidney injury (AKI). Our study reveals a disruption in de novo NAD + synthesis in proximal tubular models, but not in vivo, attributed to downregulation of enzyme kynurenine 3-monooxygenase (KMO). These findings highlight a crucial role of KMO in governing de novo NAD + biosynthesis within the kidney, shedding light on potential AKI interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial CellsKidney Tubules, ProximalKynurenine 3-MonooxygenaseNADTryptophanAnimalsHumansMiceAcute Kidney InjuryCell LineCells, CulturedKynurenineMice, Inbred C57BL

Stichwörter der Autor:innen

de novo NAD+ synthesiskynurenine 3-monooxygenasekynurenine pathwaynicotinamide adenine dinucleotiderenal proximal tubule epithelial cell

Substanzen

KynurenineKynurenine 3-MonooxygenaseNADTryptophan

Autor:innen und Institutionen

  • CVMR-PH Discovery, Johnson & Johnson Innovative Medicine Research & Development, Spring House, Pennsylvania, United States.

ORCID-Profile: Yougang Zhai

Förderung

  • Auris | J&J | Janssen Research and Development (JRD)
  • Johnson & Johnson Innovative Medicine

Zitieren

APA

Zhai, Y., Chavez, J. A., D'Aquino, K. E., Meng, R., Nawrocki, A. R., Pocai, A., Wang, L., & Ma, L. J. (2024). Kynurenine 3-monooxygenase limits de novo NAD + synthesis through dietary tryptophan in renal proximal tubule epithelial cell models. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00445.2023

Vancouver

Zhai Y, Chavez JA, D'Aquino KE, Meng R, Nawrocki AR, Pocai A, et al. Kynurenine 3-monooxygenase limits de novo NAD + synthesis through dietary tryptophan in renal proximal tubule epithelial cell models. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00445.2023

BibTeX
@article{Zhai2024,
  author = {Zhai, Yougang and Chavez, Jose A and D'Aquino, Katharine E and Meng, Rong and Nawrocki, Andrea R and Pocai, Alessandro and Wang, Lifeng and Ma, Li-Jun},
  title = {Kynurenine 3-monooxygenase limits de novo NAD + synthesis through dietary tryptophan in renal proximal tubule epithelial cell models},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  doi = {10.1152/ajpcell.00445.2023}
}
Kostenlos starten →